Newsroom

May 02, 2019

Ambry Genetics Research Highlights Need for Expanded Genetic Testing Payer Coverage for Patients At-Risk for Hereditary Breast and Ovarian Cancer

Data presented at the 2019 American Society of Breast Surgeons (ASBrS) Annual Meeting (Aliso Viejo, CA) May 2, 2019: Researchers from Ambry Genetics (Ambry), a leading clinical genetics testing company, will present results documenting discrepancies between U.S. insurer policies for genetic testing ...


Read More

April 09, 2019

Intalere Teams with Ambry Genetics to Offer Healthcare Providers Advanced Genetic Testing for Cancer Risk Assessment

St. Louis (April 9, 2019) - Intalere, the healthcare industry leader in delivering optimal cost, quality and clinical outcomes, today announced a new partnership with Ambry Genetics, a leading clinical genetic testing company. The collaboration will enable Intalere to offer its healthcare providers ...


Read More

April 02, 2019

Ambry Genetics Research Demonstrates RNA Genetic Testing in Hereditary Cancer Improves Variant Classification and Patient Management

Data presented at the 2019 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting (Aliso Viejo, CA) April 2, 2019: Researchers from Ambry Genetics (Ambry), a leading clinical genetics testing company, will present results demonstrating that RNA genetic testing ...


Read More

March 25, 2019

Ambry Genetics to Develop Custom Assays Targeted to Patients with Hereditary Ovarian Cancer

Investigating new testing options to identify patients for clinical trials Aliso Viejo, CA (March 13, 2019); Ambry Genetics, a Konica Minolta Company (Ambry), and leading provider of clinical and research genetic testing, today announced a new laboratory services agreement with Clovis Oncology ...


Read More

March 19, 2019

Konica Minolta Precision Medicine Announces the Formation of its Inaugural Scientific Advisory Board

Aliso Viejo, CA (March 19, 2019): Konica Minolta Precision Medicine, Inc. (KMPM), a subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the formation of their inaugural Scientific Advisory Board. Founded in late 2018, KMPM is dedicated to the advancement of precision medicine that ...


Read More

March 18, 2019

My Gene Counsel and Ambry Genetics Join Forces to Bridge the Gap Between Direct-To-Consumer Testing and Medical-Grade Genetic Testing

The One-Stop Solution will allow direct-to-consumer kit users to confirm their hereditary cancer results New Haven, CT - March 18, 2019 - My Gene Counsel, a digital health company that provides personalized, easy-to-understand genetic testing reports, today announced a partnership with Ambry ...


Read More

July 10, 2018

Dr. John E. Niederhuber Appointed Chairman of Konica Minolta’s Scientific Advisory Board

Aliso Viejo, CA (July 10, 2018): Konica Minolta Precision Medicine Inc., a newly formed division of Konica Minolta focused on revolutionizing personalized patient care, announced today the appointment of Dr. John E. Niederhuber as the Chairman of their Scientific Advisory Board. Late last year, ...


Read More

January 30, 2018

Ambry Genetics and Invicro Announce Partnership to Provide Enhanced Capabilities with Advanced Genomics Services to Enable Precision Medicine

Partnership provides Pharmaceutical Companies a more Comprehensive Solution in an Effort to Improve Patient Care (Aliso Viejo, CA) January 30, 2018: Ambry Genetics Corporation (Ambry), leaders in genetic testing, announced today they will partner with Invicro, a leading provider of imaging services ...


Read More

July 06, 2017

Konica Minolta to Acquire U.S.-based Ambry Genetics in a Deal Valued at US$1 billion

Tokyo and Aliso Viejo, California (July 6, 2017) - Konica Minolta, Inc. (Konica Minolta) (TOKYO: 4902) (ISIN: JP3300600008) and Ambry Genetics Corporation (Ambry) today announced the signing of a definitive agreement for a subsidiary of Konica Minolta to acquire Ambry. The transaction is partially ...


Read More